Price T Rowe Associates Inc Astrazeneca PLC Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 61,271,974 shares of AZN stock, worth $4.78 Billion. This represents 0.51% of its overall portfolio holdings.
Number of Shares
61,271,974
Previous 52,269,524
17.22%
Holding current value
$4.78 Billion
Previous $3.52 Billion
17.92%
% of portfolio
0.51%
Previous 0.47%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,246Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
-
Franklin Resources Inc San Mateo, CA17.2MShares$1.34 Billion0.38% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...